Skip to main content

Animations

MJFF Publications

5841 - 5850 of 6516 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00919-y
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s40478-025-01988-z
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Association between serum sodium and sporadic Parkinson’s disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2025.1555831
    Citation Count: 2
  • Summary Details
    OPEN
    Title: RNApysoforms: fast rendering interactive visualization of RNA isoform structure and expression in Python
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf057
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00907-2
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner
    Journal Name: Frontiers in Oncology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fonc.2025.1554059
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Clinical and genetic characterization of a progressive RBL2-associated neurodevelopmental disorder
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae363
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disorders
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awae402
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Local Regulation of Striatal Dopamine Release Shifts from Predominantly Cholinergic in Mice to GABAergic in Macaques
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/jneurosci.1692-24.2025
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf099
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.